Lara joined Ergomed in 2023 and within the Regulatory Affairs department is the Biologics and ATMP CMC and nonclinical subject matter expert. She possesses a PhD in Biotechnology with over 20 years of CMC and clinical development experience in both the Biopharma and CRO industry. Her focus has been on identifying and addressing drug development challenges in the rare disease and oncology space.